Avadel Pharmaceuticals PLC (AVDL)
10.30
-0.14
(-1.34%)
USD |
NASDAQ |
Sep 29, 16:00
10.30
0.00 (0.00%)
After-Hours: 18:53
Avadel Pharmaceuticals Enterprise Value: 793.39M for Sept. 28, 2023
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 28, 2023 | 793.39M |
| September 27, 2023 | 820.21M |
| September 26, 2023 | 858.63M |
| September 25, 2023 | 850.59M |
| September 22, 2023 | 873.83M |
| September 21, 2023 | 850.59M |
| September 20, 2023 | 864.89M |
| September 19, 2023 | 900.64M |
| September 18, 2023 | 919.40M |
| September 15, 2023 | 956.94M |
| September 14, 2023 | 956.04M |
| September 13, 2023 | 943.53M |
| September 12, 2023 | 995.37M |
| September 11, 2023 | 1.012B |
| September 08, 2023 | 1.013B |
| September 07, 2023 | 1.023B |
| September 06, 2023 | 1.041B |
| September 05, 2023 | 1.006B |
| September 01, 2023 | 1.056B |
| August 31, 2023 | 1.068B |
| August 30, 2023 | 1.102B |
| August 29, 2023 | 1.097B |
| August 28, 2023 | 1.123B |
| August 25, 2023 | 1.103B |
| August 24, 2023 | 1.094B |
| Date | Value |
|---|---|
| August 23, 2023 | 1.103B |
| August 22, 2023 | 1.068B |
| August 21, 2023 | 1.071B |
| August 18, 2023 | 997.15M |
| August 17, 2023 | 1.015B |
| August 16, 2023 | 1.029B |
| August 15, 2023 | 1.090B |
| August 14, 2023 | 1.107B |
| August 11, 2023 | 1.161B |
| August 10, 2023 | 1.061B |
| August 09, 2023 | 1.009B |
| August 08, 2023 | 1.068B |
| August 07, 2023 | 1.056B |
| August 04, 2023 | 1.076B |
| August 03, 2023 | 1.081B |
| August 02, 2023 | 1.103B |
| August 01, 2023 | 1.116B |
| July 31, 2023 | 1.120B |
| July 28, 2023 | 1.097B |
| July 27, 2023 | 1.088B |
| July 26, 2023 | 1.106B |
| July 25, 2023 | 1.093B |
| July 24, 2023 | 1.058B |
| July 21, 2023 | 1.099B |
| July 20, 2023 | 1.108B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
53.63M
Minimum
Dec 26 2018
1.332B
Maximum
Jun 30 2023
393.38M
Average
367.07M
Median
Jan 21 2020
Enterprise Value Benchmarks
| Trinity Biotech PLC | 87.21M |
| Amarin Corp PLC | 58.24M |
| Adaptimmune Therapeutics PLC | -27.03M |
| Biodexa Pharmaceuticals Plc | -2.223M |
| TC BioPharm (Holdings) PLC | -3.060M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -64.43M |
| Revenue (Quarterly) | 1.496M |
| Total Expenses (Quarterly) | 51.04M |
| EPS Diluted (Quarterly) | -0.83 |
| Gross Profit Margin (Quarterly) | 97.59% |
| Profit Margin (Quarterly) | -4.31K% |
| Earnings Yield | -20.19% |
| Normalized Earnings Yield | -19.25 |